Detection of Prostate Cancer Precursor Cells
Currently, cancer progenitor cells are a relatively new area of research with great promise.
ABS is developing a blood-based diagnostic test designed to detect the presence of circulating prostate cancer precursor cells. They are thought to be the source of recurrent cancer since they are chemo- and hypoxia-resistant and are not eliminated by surgical or radiation treatments of the bulk tumor.
ABS has identified BCRP as a marker on the prostate cancer progenitor cell.
Read more about this important topic at the links below.
© 2011 AndroBioSys Inc. | Elm and Carlton Streets, Buffalo NY 14263 | 716-845-8226
Privacy Policy | Terms and Conditions